One Patent Tossed, Two Upheld In Celebrex Appeal
A federal appeals court handed down a split decision Friday in Teva Pharmaceuticals' challenge to Pfizer Inc.'s patents for its blockbuster arthritis drug Celebrex, upholding two of Pfizer's three disputed patents...To view the full article, register now.
Already a subscriber? Click here to view full article